# Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency

> **NCT05586737** · PHASE2 · COMPLETED · sponsor: **Angelica Lindén Hirschberg** · enrollment: 15 (actual)

## Conditions studied

- Autoimmune Diseases
- Premature Ovarian Insufficiency

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT05586737
- **Lead sponsor:** Angelica Lindén Hirschberg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-29
- **Primary completion:** 2024-12-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05586737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05586737, "Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05586737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*